Publications

Publications | Masters and Phd thesis

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil

Publications

In Press | 2019 | ...

In Press

Meta-Analysis in Metastatic Uveal Melanoma to Determine Progression-Free and Overall Survival Benchmarks: an International Rare Cancers Initiative (IRCI) Ocular Melanoma study.

Khoja L., Atenafu E.G., Suciu S., Leyvraz S., Sato T., Marshall E., Keilholz U., Zimmer L., Patel S.P., Piperno-Neumann S. et al. Annals of oncology. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_BD137DAA9150]

CDK4 regulates lysosomal function and mTORC1 activation to promote cancer cell survival.

Martínez-Carreres L., Puyal J., Leal-Esteban L.C., Orpinell M., Castillo-Armengol J., Giralt A., Dergai O., Moret C., Barquissau V., Nasrallah A. et al. Cancer research. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_78F7CC0E31B9]

Diagnostic Nodes of Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Among Colorectal Cancer Patients: A Swiss National Multicenter Survey.

Steffen T., Putora P.M., Hübner M., Gloor B., Lehmann K., Kettelhack C., Adamina M., Peterli R., Schmidt J., Ris F. et al. Clinical colorectal cancer. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_A52BDCE5AABD]

The pro- and anti-tumor role of ILC2s.

Trabanelli S., Chevalier M.F., Derré L., Jandus C. Seminars in immunology. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_ECAD6DCB8107]

2019

Cancer Immunotherapy: A Simple Guide for Interventional Radiologists of New Therapeutic Approaches.

Digklia A., Duran R., Homicsko K., Kandalaft L.E., Hocquelet A., Orcurto A., Coukos G., Denys A., 2019/09. Cardiovascular and interventional radiology, 42 (9) pp. 1221-1229. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_13E5E5B29D1D]

Biomodulina T partially restores immunosenescent CD4 and CD8 T cell compartments in the elderly.

Saavedra D., Fuertes S.A., Suárez G.M., González A., Lorenzo-Luaces P., García B., Aznar E., Mazorra Z., Crombet T., Speiser D.E. et al., 2019/09. Experimental gerontology, 124 p. 110633. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_6E061DCF6353]

Epigenetic Control of Mitochondrial Fission Enables Self-Renewal of Stem-like Tumor Cells in Human Prostate Cancer

Civenni Gianluca, Bosotti Roberto, Timpanaro Andrea, Vàzquez Ramiro, Merulla Jessica, Pandit Shusil, Rossi Simona, Albino Domenico, Allegrini Sara, Mitra Abhishek et al., 2019/08. Cell Metabolism, 30 (2) pp. 303-318.e6. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_160F9BD5E05B]

Rational combinations of immunotherapy with radiotherapy in ovarian cancer.

Herrera F.G., Irving M., Kandalaft L.E., Coukos G., 2019/08. The Lancet. Oncology, 20 (8) pp. e417-e433. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_B919A825548B]

18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer.

Jreige M., Letovanec I., Chaba K., Renaud S., Rusakiewicz S., Cristina V., Peters S., Krueger T., de Leval L., Kandalaft L.E. et al., 2019/08. European journal of nuclear medicine and molecular imaging, 46 (9) pp. 1859-1868. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_4F575C6723CE]

Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting.

Yu Y.R., Ho P.C., 2019/08. Clinical and experimental immunology, 197 (2) pp. 153-160. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_4F2A32ECC9A7]

High-throughput Screening of Human Tumor Antigen-specific CD4 T Cells, Including Neoantigen-reactive T Cells.

Costa-Nunes C., Cachot A., Bobisse S., Arnaud M., Genolet R., Baumgaertner P., Speiser D.E., Sousa Alves P.M., Sandoval F., Adotévi O. et al., 2019/07/15. Clinical cancer research, 25 (14) pp. 4320-4331. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_99ED3D648751]

Attenuation of chronic antiviral T-cell responses through constitutive COX2-dependent prostanoid synthesis by lymph node fibroblasts

Schaeuble Karin, Cannelle Hélène, Favre Stéphanie, Huang Hsin-Ying, Oberle Susanne G., Speiser Daniel E., Zehn Dietmar, Luther Sanjiv A., 2019/07/15. PLoS biology, 17 (7) pp. e3000072. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_6C21F8646A14]

Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors.

Ayeni D., Miller B., Kuhlmann A., Ho P.C., Robles-Oteiza C., Gaefele M., Levy S., de Miguel F.J., Perry C., Guan T. et al., 2019/07/10. Journal for immunotherapy of cancer, 7 (1) p. 172. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_765E95D84B97]

SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules.

Daina A., Michielin O., Zoete V., 2019/07/02. Nucleic acids research, 47 (W1) pp. W357-W364. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_37625953AF4B]

Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer.

Berner F., Bomze D., Diem S., Ali O.H., Fässler M., Ring S., Niederer R., Ackermann C.J., Baumgaertner P., Pikor N. et al., 2019/07/01. JAMA oncology, 5 (7) pp. 1043-1047. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_D4ABE4711190]

TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection.

Alfei F., Kanev K., Hofmann M., Wu M., Ghoneim H.E., Roelli P., Utzschneider D.T., von Hoesslin M., Cullen J.G., Fan Y. et al., 2019/07. Nature, 571 (7764) pp. 265-269. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_00D136C4113F]

Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.

Li X., Wenes M., Romero P., Huang S.C., Fendt S.M., Ho P.C., 2019/07. Nature reviews. Clinical oncology, 16 (7) pp. 425-441. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_F7C5AE601718]

RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.

Gbenedio O.M., Bonnans C., Grun D., Wang C.Y., Hatch A.J., Mahoney M.R., Barras D., Matli M., Miao Y., Garcia K.C. et al., 2019/06/25. JCI insight, 5. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_3AFCE6869632]

Mass spectrometry driven exploration reveals nuances of neoepitope-driven tumor rejection.

Ebrahimi-Nik H., Michaux J., Corwin W.L., Keller G.L., Shcheglova T., Pak H., Coukos G., Baker B.M., Mandoiu I.I., Bassani-Sternberg M. et al., 2019/06/20. JCI insight, 5. Peer-reviewed.

[DOI] [Pmid] [serval:BIB_77410C339277]

Internal radiation dosimetry of a <sup>152</sup>Tb-labeled antibody in tumor-bearing mice.

Cicone F., Gnesin S., Denoël T., Stora T., van der Meulen N.P., Müller C., Vermeulen C., Benešová M., Köster U., Johnston K. et al., 2019/06/11. EJNMMI research, 9 (1) p. 53. Peer-reviewed.

[DOI] [WoS] [Pmid] [serval:BIB_22C26DF26A4B]

Masters thesis

Publications (1)

CANCER IMMUNOTHERAPY WITH VEGFR-3 TARGETED CAR T-CELLS

KIRITSIS K., 2016. 32, Université de Lausanne, Faculté de biologie et médecine, COUKOS G. (dir.).

[URN] [serval:BIB_AD0E970E95CE]

Phd thesis

Publications (4)

Molecular and functional immune determinants associated with the optimal immunogenicity of Yellow Fever vaccination in humans

Bovay Amandine Xuan Kim, 2019/06/07., Université de Lausanne, Faculté de biologie et médecine, Speiser Daniel (dir.).

[URN] [serval:BIB_5EBE536D2CB3]

Molecular determinants governing CD8+ T cell mediated anti-tumor immunity

Martinez-Usatorre Amaia, 2018/04/27. 117, Université de Lausanne, Faculté de biologie et médecine, Romero Pedro (dir.).

[URN] [serval:BIB_08CEE3B79D75]

Harnessing iNKT and CD8 T cells for Immunotherapy of Cancer

Tschumi Benjamin Olivier, 2018/03/13. 117, Université de Lausanne, Faculté de biologie et médecine, Romero Pedro (dir.).

[URN] [serval:BIB_786BC3B46C6D]

Characterization of local and systemic immune-modulation in melanoma patients

Bordy N., 2015. 204, Université de Lausanne, Faculté de biologie et médecine, Speiser D., Swartz M. (dir.).

[URN] [serval:BIB_9F9512EEBA1F]